Post-stroke Cognitive Impairment

NCT ID: NCT05653141

Last Updated: 2024-11-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

335 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-12-17

Study Completion Date

2026-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Present study aims to track the post-stroke cognitive trajectories and to investigate its inter-individual variability.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study aim is to establish a model capturing patients' inter-individual variability in susceptibility to stroke damage to predict stroke-induced cognitive trajectories. This is a prospective longitudinal observational national monocentric study for 6 years (recruitment during the first 3 years). The investigators perform comprehensive neuropsychological testing in i) acute stroke phase (0-10 days post-stroke), ii) sub-acute stroke phase (3 months post-stroke), and iii) chronic stroke phase (12 months and 3 years post-stroke). At each time point, cognitive performances as well as clinical and functional status will be assessed. Furthermore, the investigators will assess the proxies of cognitive reserve and the level of post-stroke physical activity.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

First-ever Ischemic Stroke Cognitive Performance

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Stroke patients

Adults with first-ever anterior circulation stroke

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥18 years old
* First-ever anterior circulation ischemic stroke confirmed by routine MRI
* Time of enrollment: ≤ 10 days from stroke onset.

Exclusion Criteria

* Previous stroke anamnestic or based on clinical imaging
* Additional stroke in posterior circulation
* Conditions that preclude the cognitive testing (e.g. delirium, intubation, reduced vigilance
* Neurological or psychiatric conditions that preclude the data interpretation (e.g. pre-stroke dementia, schizophrenia, brain tumor, regular intake of benzodiazepine, depression)
* MRI contraindication
* Native language other than German, French or Italian
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Roza Umarova

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Roza Umarova

PD Dr., Principal Investigator, Head of out-patient clinic of cognitive neurology

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Roza M. Umarova, PD Dr.

Role: PRINCIPAL_INVESTIGATOR

Department of Neurology, Inselspital, University Hospital Bern, University of Bern

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Neurology, Inselspital, University Hospital Bern, University of Bern

Bern, , Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

References

Explore related publications, articles, or registry entries linked to this study.

Umarova RM. Adapting the concepts of brain and cognitive reserve to post-stroke cognitive deficits: Implications for understanding neglect. Cortex. 2017 Dec;97:327-338. doi: 10.1016/j.cortex.2016.12.006. Epub 2016 Dec 16.

Reference Type BACKGROUND
PMID: 28049565 (View on PubMed)

Gallucci L, Sperber C, Monsch AU, Kloppel S, Arnold M, Umarova RM. Improving diagnostic accuracy of the Montreal Cognitive Assessment to identify post-stroke cognitive impairment. Sci Rep. 2024 Aug 29;14(1):20125. doi: 10.1038/s41598-024-71184-x.

Reference Type DERIVED
PMID: 39209968 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Studien-Nr. 4599

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.